ResearcherUniversity of BernActive in the last 2 years
Konstantin Bräutigam
Matched on ORCID iD 0000-0002-3966-3579; OpenAlex author ID A5035986920. Sources: OpenAlex.
Their work
- Papers
- 4 (first author 2, last author 0)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 15
2025: 2 papers · 2026: 2 papers
Papers 4
- Direct Tumor-Adipocyte Contact as a Prognostic Biomarker in Resected Pancreatic Ductal Adenocarcinoma. First author DOI 10.1016/j.ejca.2026.117035↗
- RNF43 Mutations Are Associated With the Classical Molecular Subtype, Vigorous Antitumor Immune Responses, and Prolonged Survival in Pancreatic Adenocarcinoma. First author DOI 10.1016/j.modpat.2026.101010↗
- Tumor immune microenvironment in pancreatic ductal adenocarcinoma revisited - Exploring the "Space". Co-author DOI 10.1016/j.canlet.2025.217699↗
- Spatially resolved analysis of TGF/BMP signalling in pancreatic ductal adenocarcinoma by digital pathology identifies patient subgroups with adverse outcome. Co-author DOI 10.1186/s12885-025-14751-3↗
Closest collaborators
The 15 strongest of 15 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Anna Silvia Wenning · 3 shared papers, 2025–2026 · strength 0.82
- Paper RNF43 Mutations Are Associated With the Classical Molecular Subtype, Vigorous Antitumor Immune Responses, and Prolonged… DOI 10.1016/j.modpat.2026.101010↗
- Paper Spatially resolved analysis of TGF/BMP signalling in pancreatic ductal adenocarcinoma by digital pathology identifies p… DOI 10.1186/s12885-025-14751-3↗
- Paper Direct Tumor-Adipocyte Contact as a Prognostic Biomarker in Resected Pancreatic Ductal Adenocarcinoma. DOI 10.1016/j.ejca.2026.117035↗
- Beat Gloor · 3 shared papers, 2025–2026 · strength 0.82
- Paper RNF43 Mutations Are Associated With the Classical Molecular Subtype, Vigorous Antitumor Immune Responses, and Prolonged… DOI 10.1016/j.modpat.2026.101010↗
- Paper Spatially resolved analysis of TGF/BMP signalling in pancreatic ductal adenocarcinoma by digital pathology identifies p… DOI 10.1186/s12885-025-14751-3↗
- Paper Direct Tumor-Adipocyte Contact as a Prognostic Biomarker in Resected Pancreatic Ductal Adenocarcinoma. DOI 10.1016/j.ejca.2026.117035↗
- Eva Karamitopoulou · 2 shared papers, 2025–2026 · strength 0.66
- Paper RNF43 Mutations Are Associated With the Classical Molecular Subtype, Vigorous Antitumor Immune Responses, and Prolonged… DOI 10.1016/j.modpat.2026.101010↗
- Paper Tumor immune microenvironment in pancreatic ductal adenocarcinoma revisited - Exploring the "Space". DOI 10.1016/j.canlet.2025.217699↗
- Martin Wartenberg · 2 shared papers, 2025–2026 · strength 0.48
- Aurel A. Perren · 1 shared paper, 2026 · strength 0.33
- Pauline Aeschbacher · 1 shared paper, 2026 · strength 0.33
- Animesh Acharjee · 1 shared paper, 2026 · strength 0.33
- K Szymoński · 1 shared paper, 2025 · strength 0.33
- Michael Guenther · 1 shared paper, 2026 · strength 0.23
- Nic G. Reitsam · 1 shared paper, 2026 · strength 0.23
- Steffen Ormanns · 1 shared paper, 2026 · strength 0.23
- Bruno Märkl · 1 shared paper, 2026 · strength 0.23
- Przemyslaw Grochowski · 1 shared paper, 2026 · strength 0.23
- Robert Grützmann · 1 shared paper, 2026 · strength 0.23
- Christian P. Pilarsky · 1 shared paper, 2026 · strength 0.23
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.